FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: Relationship to histologic type, treatment algorithm, and survival

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 5, 2011, Pages 810-821

  Gerbaudo, Victor H ^a   Mamede, Marcelo ^a   Trotman Dickenson, Beatrice ^a   Hatabu, Hiroto ^a   Sugarbaker, David J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

FDG; FDG PET CT; Lung cancer; Mesothelioma; Recurrence; Response to treatment; Survival

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; GEMCITABINE; METHOTREXATE; MITOMYCIN; MITOXANTRONE; NAVELBINE; PEMETREXED;

ADULT; AGED; ARTICLE; BRONCHOPLEURAL FISTULA; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG RESECTION; LYMPH NODE METASTASIS; MALE; MALIGNANT PLEURA MESOTHELIOMA; OVERALL SURVIVAL; PLEURA EMPYEMA; PLEURA MESOTHELIOMA; PLEURECTOMY; PROGNOSIS; PROGRESSION FREE SURVIVAL; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE;

ABDOMEN; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BIOLOGICAL TRANSPORT; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHY, ABDOMINAL; RADIOGRAPHY, THORACIC; RETROSPECTIVE STUDIES; THORAX; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE;

EID: 79953709689     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1704-x     Document Type: Article

References (42)

1. VW Rusch S Piantadosi EC Holmes 1991 The role of extrapleural pneumonectomy in malignant pleural mesothelioma: a Lung Cancer Study Group trial J Thorac Cardiovasc Surg 102 1 9 2072706 1:STN:280:DyaK3MzgsVSisg%3D%3D
2. HI Pass K Kranda BK Temeck I Feuerstein SM Steinberg 1997 Surgically debulked malignant pleural mesothelioma: results and prognostic factors Ann Surg Oncol 4 215 222 9142382 10.1007/BF02306613 1:STN:280:DyaK2s3oslaqsg%3D%3D (Pubitemid 127725247)
3. BS Hilaris D Nori E Kwong GJ Kutcher N Martini 1984 Pleurectomy and intraoperative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma Int J Radiat Oncol Biol Phys 10 325 331 6706729 10.1016/0360-3016(84)90050-6 1:STN:280:DyaL2c7mtFCgtA%3D%3D (Pubitemid 14110165)
4. VW Rusch K Rosenzweig E Venkatraman L Leon A Raben L Harrison, et al. 2001 A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma J Thorac Cardiovasc Surg 122 788 795 11581615 10.1067/mtc.2001.116560 1:STN:280:DC%2BD3MrjsVektQ%3D%3D (Pubitemid 35470127)
5. LR Holsti S Pyrhönen M Kajanti M Mäntylä K Mattson P Maasilta, et al. 1997 Altered fractionation of hemithorax irradiation for pleural mesothelioma and failure patterns after treatment Acta Oncol 36 397 405 9247101 10.3109/02841869709001287 1:STN:280:DyaK2szovValtQ%3D%3D (Pubitemid 27298560)
6. HI Pass BK Temeck K Kranda G Thomas A Russo P Smith, et al. 1997 Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma Ann Surg Oncol 4 628 633 9416409 10.1007/BF02303746 1:STN:280: DyaK1c%2FnvVeltw%3D%3D (Pubitemid 127725490)
7. V Rusch L Saltz E Venkatraman R Ginsberg P McCormack M Burt, et al. 1994 A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma J Clin Oncol 12 1156 1163 8201377 1:STN:280:DyaK2c3mtValsw%3D%3D (Pubitemid 24173928)
8. TW Rice DJ Adelstein TJ Kirby MG Saltarelli SR Murthy MA Van Kirk, et al. 1994 Aggressive multimodality therapy for malignant pleural mesothelioma Ann Thorac Surg 58 24 29 7518666 10.1016/0003-4975(94)91066-9 1:STN:280: DyaK2czhtFKrug%3D%3D (Pubitemid 24243900)
9. EH Baldini A Recht GM Strauss MM DeCamp SJ Swanson MJ Liptay, et al. 1997 Patterns of failure after trimodality therapy for malignant pleural mesothelioma Ann Thorac Surg 63 2 334 338 9033296 10.1016/S0003-4975(96)01228-3 1:STN:280:DyaK2s7osFKitw%3D%3D (Pubitemid 27084548)
10. PA Jänne EH Baldini 2004 Patterns of failure following surgical resection for malignant pleural mesothelioma Thorac Surg Clin 14 4 567 573 15559064 10.1016/j.thorsurg.2004.06.006 (Pubitemid 39314491)
11. RR Gill VH Gerbaudo DJ Sugarbaker H Hatabu 2009 Current trends in radiologic management of malignant pleural mesothelioma Semin Thorac Cardiovasc Surg 21 2 111 120 19822282 10.1053/j.semtcvs.2009.06.011
12. M Yamamuro VH Gerbaudo RR Gill FL Jacobson DJ Sugarbaker H Hatabu 2007 Morphologic and functional imaging of malignant pleural mesothelioma Eur J Radiol 64 3 356 366 17954021 10.1016/j.ejrad.2007.08.010 (Pubitemid 350116492)
13. F Bénard D Sterman RJ Smith LR Kaiser SM Albelda A Alavi 1998 Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography Chest 114 713 722 9743156 10.1378/chest.114.3.713 (Pubitemid 28433730)
14. DB Schneider C Clary-Macy S Challa KC Sasse SH Merrick R Hawkins, et al. 2000 Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma J Thorac Cardiovasc Surg 120 128 133 10884665 10.1067/mtc.2000.106529 1:STN:280: DC%2BD3czovVWisg%3D%3D (Pubitemid 30471221)
15. A Carretta C Landoni G Melloni GL Ceresoli A Compierchio F Fazio, et al. 2000 18-FDG positron emission tomography in the evaluation of malignant pleural diseases - a pilot study Eur J Cardiothorac Surg 17 377 383 10773558 10.1016/S1010-7940(00)00377-8 1:STN:280:DC%2BD3c3jslagsw%3D%3D (Pubitemid 30204484)
16. VH Gerbaudo DJ Sugarbaker S Britz-Cunningham MF Di Carli C Mauceri ST Treves 2002 Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology J Nucl Med 43 1144 1149 12215551 (Pubitemid 34988759)
17. VH Gerbaudo 2003 18F-FDG imaging of malignant pleural mesothelioma: scientiam impendere vero Nucl Med Commun 24 6 609 614 12766595 10.1097/00006231-200306000-00001 1:STN:280:DC%2BD3s3ksVWkug%3D%3D
18. JJ Erasmus MT Truong WR Smythe RF Munden EM Marom DC Rice, et al. 2005 Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: staging implications J Thorac Cardiovasc Surg 129 6 1364 1370 15942579 10.1016/j.jtcvs.2004.10.034 (Pubitemid 40804856)
19. D Fiore V Baggio G Sotti PC Muzzio 2006 Imaging before and after multimodal treatment for malignant pleural mesothelioma Radiol Med 111 3 355 364 16683083 10.1007/s11547-006-0034-3 1:STN:280:DC%2BD283lvFSjsQ%3D%3D
20. C Tan S Barrington S Rankin D Landau J Pilling J Spicer, et al. 2010 Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesothelioma J Thorac Oncol 5 3 385 388 20087231 10.1097/JTO. 0b013e3181cbf465
21. J Ikezoe K Kadowaki S Morimoto S Takashima T Kozuka K Nakahara, et al. 1990 Mediastinal lymph node metastases from nonsmall cell bronchogenic carcinoma: reevaluation with CT J Comput Assist Tomogr 14 3 340 344 2159492 10.1097/00004728-199005000-00003 1:STN:280:DyaK3c3ktlyrsg%3D%3D (Pubitemid 20162550)
22. VH Gerbaudo S Britz-Cunningham DJ Sugarbaker ST Treves 2003 Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma Thorax 58 12 1077 1082 14645979 10.1136/thorax.58.12.1077 1:STN:280:DC%2BD3srnt1Wgug%3D%3D (Pubitemid 37542115)
23. HA Jones RJ Clark CG Rhodes JB Schofield T Krausz C Haslett 1991 Positron emission tomography of 18FDG uptake in localized pulmonary inflammation Acta Radiol Suppl 376 148 1666756 1:STN:280:DyaK383hsVWktw%3D%3D
24. LG Strauss 1996 Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients Eur J Nucl Med 23 1409 1415 8781149 10.1007/BF01367602 1:STN:280:DyaK28zns1GhtA%3D%3D (Pubitemid 26340597)
25. H Zhuang M Pourdehnad AJ Yamamoto MD Rossman A Alavi 2001 Intense F-18 fluorodeoxyglucose uptake caused by mycobacterium avium intracellulare infection Clin Nucl Med 26 5 458 11317033 10.1097/00003072-200105000-00020 1:STN:280:DC%2BD3MvjsFGhtw%3D%3D (Pubitemid 32373783)
26. A Alavi N Gupta JL Alberini M Hickeson LE Adam P Bhargava, et al. 2002 Positron emission tomography imaging in nonmalignant thoracic disorders Semin Nucl Med 32 4 293 321 12524653 10.1053/snuc.2002.127291 (Pubitemid 35332975)
27. H Zhuang PS Duarte A Rebenstock Q Feng A Alavi 2003 Pulmonary clostridium perfringens infection detected by FDG positron emission tomography Clin Nucl Med 28 6 517 518 12917543 10.1097/00003072-200306000-00020 (Pubitemid 38295238)
28. T Inoue EE Kim R Komaki FC Wong P Bassa WH Wong, et al. 1995 Detecting recurrent or residual lung cancer with FDG-PET J Nucl Med 36 5 788 793 7738649 1:STN:280:DyaK2M3ls12ksw%3D%3D
29. U Nestle D Hellwig J Fleckenstein K Walter D Ukena C Rübe, et al. 2002 Comparison of early pulmonary changes in 18FDG-PET and CT after combined radiochemotherapy for advanced non-small-cell lung cancer: a study in 15 patients Front Radiat Ther Oncol 37 26 33 11764664 10.1159/000061294
30. M Sonobe M Nawkagawa M Ichinose N Ikegami M Nagasawa T Shindo 2000 Analysis of risk factors in bronchopleural fistula after pulmonary resection for primary lung cancer Eur J Cardiothorac Surg 18 519 523 11053810 10.1016/S1010-7940(00)00541-8 1:STN:280:DC%2BD3M%2FosFyrtQ%3D%3D
31. HA Jones RJ Clark CG Rhodes JB Schofield T Krausz C Haslett 1994 In vivo measurement of neutrophil activity in experimental lung inflammation Am J Respir Crit Care Med 149 6 1635 1639 7516252 1:STN:280:DyaK2c3nt1Ontg%3D%3D (Pubitemid 24175987)
32. HA Jones KA Cadwallader JF White M Uddin AM Peters ER Chilvers 2002 Dissociation between respiratory burst activity and deoxyglucose uptake in human neutrophil granulocytes: implications for interpretation of (18)F-FDG PET images J Nucl Med 43 5 652 657 11994530 1:CAS:528:DC%2BD38XktlOltbc%3D (Pubitemid 34507118)
33. L Zellos DC Christiani 2004 Epidemiology, biologic behavior, and natural history of mesothelioma Thorac Surg Clin 14 4 469 477 15559053 10.1016/j.thorsurg.2004.06.011 (Pubitemid 39314480)
34. ST Lee M Ghanem RA Herbertson SU Berlangieri AJ Byrne K Tabone, et al. 2009 Prognostic value of (18)F-FDG PET/CT in patients with malignant pleural mesothelioma Mol Imaging Biol 11 6 473 479 19330385 10.1007/s11307-009-0203-6 1:STN:280:DC%2BD1Mnps1Siug%3D%3D
35. KS Panageas L Ben-Porat MN Dickler PB Chapman D Schrag 2007 When you look matters: the effect of assessment schedule on progression-free survival J Natl Cancer Inst 99 6 428 432 17374832 10.1093/jnci/djk091 (Pubitemid 47073565)
36. WG Richards L Zellos R Bueno MT Jaklitsch PA Jänne LR Chirieac, et al. 2006 Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma J Clin Oncol 24 10 1561 1567 16575008 10.1200/JCO.2005.04.6813 1:CAS:528:DC%2BD28XjvFykt78%3D (Pubitemid 46638779)
37. GL Ceresoli A Chiti PA Zucali F Cappuzzo F De Vincenzo R Cavina, et al. 2007 Assessment of tumor response in malignant pleural mesothelioma Cancer Treat Rev 33 6 533 541 17764849 10.1016/j.ctrv.2007.07.012 (Pubitemid 47355343)
38. RM Flores T Akhurst M Gonen M Zakowski J Dycoco SM Larson, et al. 2006 Positron emission tomography predicts survival in malignant pleural mesothelioma J Thorac Cardiovasc Surg 132 4 763 768 17000285 10.1016/j.jtcvs.2006.03.068 (Pubitemid 44415880)
39. AK Nowak RJ Francis MJ Phillips MJ Millward AA van der Schaaf J Boucek, et al. 2010 A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters Clin Cancer Res 16 8 2409 2417 20371686 10.1158/1078-0432.CCR-09-2313 1:CAS:528:DC%2BC3cXkslSls7Y%3D
40. J Jassem R Ramlau A Santoro W Schuette A Chemaissani S Hong, et al. 2008 Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma J Clin Oncol 26 10 1698 1704 18375898 10.1200/JCO.2006.09.9887 1:CAS:528:DC%2BD1cXltlWhs74%3D
41. NJ Vogelzang JJ Rusthoven J Symanowski C Denham E Kaukel P Ruffie, et al. 2003 Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma J Clin Oncol 21 14 2636 2644 12860938 10.1200/JCO.2003.11.136 1:CAS:528:DC%2BD2cXptlCktL4%3D (Pubitemid 46606305)
42. JP van Meerbeeck R Gaafar C Manegold RJ Van Klaveren EA Van Marck M Vincent, et al. 2005 Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada J Clin Oncol 23 28 6881 6889 16192580 10.1200/JCO.20005.14.589